Urinary Tract Infections (UTIs)
8
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Trial of Reducing Inpatient Antibiotic Durations in Children
Antibiofilm Activity of Chitosan Nanoparticles Against Uropathogenic Escherichia Coli
Effects of Pomegranate Seed Oil Supplementation in Patients With Advanced Dementia
Evaluation of the Effectiveness and Safety of a Vaginal Gel for Prevention of Recurrent Urinary Tract Infections
Community Antibiotic Use, Susceptibility and ResisTance Among Patients With Urinary Tract Infections (CAST-UTI)
Lactobacillus Probiotic for Prevention of UTI
The Efficacy of Orally Administrated Probiotic Formula in Preventing a Recurrence of a Urinary Tract Infection During Pregnancy
Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Family Physicians